Business Context and Reporting Period
Company: New Horizon Aircraft Ltd. (HOVR)
Filing Type: Form 10-K (Annual Report)
Reporting Period: Fiscal year ended May 31, 2025
Business Overview: New Horizon is an advanced aerospace OEM designing the Cavorite X7, a hybrid-electric Vertical Takeoff and Landing (eVTOL) aircraft for the Regional Air Mobility (RAM) market. The company utilizes proprietary "HOVR Wing" technology (ducted fans inside wings) to achieve vertical lift and efficient forward flight. As of the filing date, the company is in the pre-revenue development phase, having completed flight testing on a 50%-scale prototype and currently building a full-scale technical demonstrator. Commercialization and Type Certification are targeted for 2028–2030.
Key Financial Metrics (Fiscal Year Ended May 31, 2025)
| Metric | 2025 (CAD '000s) | 2024 (CAD '000s) |
|---|---|---|
| Revenue | $0 | $0 |
| Net Income (Loss) | $5,200 | $(8,160) |
| Operating Expenses | $13,585 | $4,624 |
| Research & Development | $3,660 | $880 |
| General & Administrative | $9,925 | $3,744 |
| Cash and Cash Equivalents (End of Period) | $7,547 | $1,816 |
| Net Cash Used in Operating Activities | $(9,312) | $(3,308) |
| Net Cash Provided by Financing Activities | $15,185 | $5,105 |
| Total Assets | $8,412 | $4,944 |
| Total Liabilities | $5,822 | $22,877 |
| Shareholders' Equity | $2,590 | $(17,933) |
Note: All figures are in thousands of Canadian Dollars (CAD) unless otherwise noted. The 2025 Net Income is primarily driven by a non-cash gain on the termination of a Forward Purchase Agreement.
Material Changes vs. Prior Period
- Profitability Shift: The company reported a Net Income of $5.2 million in 2025 compared to a Net Loss of $8.2 million in 2024. This reversal is not due to operational profitability but is driven by a $21.4 million non-cash gain from the termination of a Forward Purchase Agreement and a $2.0 million loss from changes in the fair value of warrants.
- Operating Expense Surge: Total operating expenses increased by 194% (from $4.6M to $13.6M). R&D expenses grew 318% due to increased labor for flight testing and engineering. G&A expenses grew 165% due to costs associated with public company compliance, legal, and investor relations.
- Liquidity Improvement: Cash and cash equivalents increased from $1.8 million to $7.5 million, bolstered by $15.2 million in net financing proceeds from share issuances, warrant exercises, and a registered securities offering.
- Liability Reduction: Total liabilities decreased significantly from $22.9 million to $5.8 million, primarily due to the removal of the $20.9 million Forward Purchase Agreement liability upon its termination in November 2024.
Guidance, Outlook, Risks, and Unusual Items
Outlook and Guidance
- Commercialization: The company does not expect to generate significant revenue until Type Certification is achieved, targeted for prior to 2030. Full-scale flight testing is expected to commence in 2026 or 2027.
- Liquidity: Management estimates current cash proceeds are sufficient to fund operations for at least the next 12 months. However, substantial doubt exists regarding the ability to continue as a going concern beyond that period without additional capital.
- Capital Needs: The company anticipates significant increases in operating expenses in fiscal 2026 and beyond to support design, certification, and manufacturing scaling.
Risks and Contingencies
- Going Concern: The auditor has issued a "Material Uncertainty Related to Going Concern" opinion due to cumulative losses and negative operating cash flows.
- Regulatory Certification: There is no assurance that the Cavorite X7 will receive Type Certification from the TCCA or FAA in a timely manner or at all. Failure to certify will prevent commercial sales.
- Internal Controls: Management concluded that disclosure controls and procedures were not effective as of May 31, 2025, citing a material weakness related to inadequate separation of financial responsibilities.
- Restatement: The company restated financial statements for the year ended May 31, 2023, reclassifying deferred development costs to R&D expenses.
- Nasdaq Compliance: The company previously faced delisting risks regarding bid price and net income standards but regained compliance as of June 2025.
Unusual Items
- Forward Purchase Agreement Termination: A $21.4 million gain was recorded upon the mutual termination of a Forward Purchase Agreement in November 2024.
- Derivative Liabilities: Significant volatility in the fair value of warrant liabilities impacted the income statement ($2.0M loss in 2025).
Investor Verification Checklist
- Cash Runway: Verify the sufficiency of the $7.5M cash balance against the projected burn rate for the next 12 months, given the "substantial doubt" on going concern.
- Certification Timeline: Confirm the status of the partnership with Cert Centre Canada (3C) and the specific milestones for TCCA Type Certification, as revenue is entirely dependent on this.
- Internal Control Remediation: Review the specific steps management is taking to remediate the material weakness in internal controls over financial reporting.
- Dilution Risk: Assess the impact of the "At-the-Market" (ATM) sales agreement and outstanding warrants (approx. 15.3M warrants) on future shareholder dilution.
- Revenue Model: Scrutinize the assumptions regarding the Regional Air Mobility (RAM) market adoption and the dual-use (civilian/military) strategy, as no commercial revenue exists yet.